These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 20020652)
41. Mucosal secretion changes during radiotherapy in the oral cavity. Aziz L; Ebenfelt A Clin Oral Investig; 2007 Sep; 11(3):293-6. PubMed ID: 17522903 [TBL] [Abstract][Full Text] [Related]
42. Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer? Yahya S; Benghiat H; Nightingale P; Tiffany M; Sanghera P; Hartley A Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e216-e219. PubMed ID: 27593973 [TBL] [Abstract][Full Text] [Related]
43. Use of Rasch analysis in the evaluation of the Oropharyngeal Mucositis Quality Of Life Scale. Cheng KK; Lee J; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR Nurs Res; 2011; 60(4):256-63. PubMed ID: 21691240 [TBL] [Abstract][Full Text] [Related]
44. In-vivo longitudinal imaging of microvascular changes in irradiated oral mucosa of radiotherapy cancer patients using optical coherence tomography. Maslennikova AV; Sirotkina MA; Moiseev AA; Finagina ES; Ksenofontov SY; Gelikonov GV; Matveev LA; Kiseleva EB; Zaitsev VY; Zagaynova EV; Feldchtein FI; Gladkova ND; Vitkin A Sci Rep; 2017 Nov; 7(1):16505. PubMed ID: 29184130 [TBL] [Abstract][Full Text] [Related]
45. [Oral mucositis as the most common complication of childhood cancer therapy. Review of the literature]. Nemes J; Jenei Á; Márton I Orv Hetil; 2018 Apr; 159(13):495-502. PubMed ID: 29577762 [TBL] [Abstract][Full Text] [Related]
46. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Dean JA; Welsh LC; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):263-273. PubMed ID: 28057404 [TBL] [Abstract][Full Text] [Related]
47. In vivo optical coherence tomography-based scoring of oral mucositis in human subjects: a pilot study. Kawakami-Wong H; Gu S; Hammer-Wilson MJ; Epstein JB; Chen Z; Wilder-Smith P J Biomed Opt; 2007; 12(5):051702. PubMed ID: 17994875 [TBL] [Abstract][Full Text] [Related]
48. Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer. Pauloski BR; Rademaker AW; Logemann JA; Lundy D; Bernstein M; McBreen C; Santa D; Campanelli A; Kelchner L; Klaben B; Discekici-Harris M Head Neck; 2011 Jun; 33(6):774-9. PubMed ID: 20737496 [TBL] [Abstract][Full Text] [Related]
50. A prospective study to assess in vivo optical coherence tomography imaging for early detection of chemotherapy-induced oral mucositis. Calantog A; Hallajian L; Nabelsi T; Mansour S; Le A; Epstein J; Wilder-Smith P Lasers Surg Med; 2013 Jan; 45(1):22-7. PubMed ID: 23322707 [TBL] [Abstract][Full Text] [Related]
52. Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients. Kuiken NS; Rings EH; Tissing WJ Crit Rev Oncol Hematol; 2015 Apr; 94(1):87-97. PubMed ID: 25560731 [TBL] [Abstract][Full Text] [Related]
53. Biomarkers of regimen-related mucosal injury. Gibson RJ; Bowen JM Cancer Treat Rev; 2011 Oct; 37(6):487-93. PubMed ID: 21689887 [TBL] [Abstract][Full Text] [Related]
54. [Diagnostic value of optical coherence tomography for oral leukoplakia assessment]. Syomkin VA; Rabinovich OF; Agapitova LP; Bezrukov AA; Babichenko II Stomatologiia (Mosk); 2018; 97(1):37-39. PubMed ID: 29465074 [TBL] [Abstract][Full Text] [Related]
55. Comparison of radiation-induced oral mucositis scoring systems. Etiz D; Orhan B; Demirüstü C; Ozdamar K; Cakmak A Tumori; 2002; 88(5):379-84. PubMed ID: 12487555 [TBL] [Abstract][Full Text] [Related]
56. [Mycoplasma pneumoniae-induced severe mucositis]. Artés Figueres M; Oltra Benavent M; Fernández Calatayud A; Revert Gomar M An Pediatr (Barc); 2009 Dec; 71(6):573-4. PubMed ID: 19811961 [No Abstract] [Full Text] [Related]
57. Oropharyngeal mucositis-specific quality-of-life measure in patients with cancer therapy. Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR Hong Kong Med J; 2010 Jun; 16 Suppl 3():42-6. PubMed ID: 20601734 [No Abstract] [Full Text] [Related]
58. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Peterson DE; Boers-Doets CB; Bensadoun RJ; Herrstedt J; Ann Oncol; 2015 Sep; 26 Suppl 5():v139-51. PubMed ID: 26142468 [No Abstract] [Full Text] [Related]
59. [Optic coherent tomography in evaluation of the buccal mucosa status. Communication 1. Normal mucosa]. Fomina IuV; Urutina MN; Leont'ev VK; Gladkova ND; Gazhva SI; Snopova LB; Gelikonov GV; Kamenskiĭ VA Stomatologiia (Mosk); 2004; 83(3):15-21. PubMed ID: 15159742 [TBL] [Abstract][Full Text] [Related]
60. Severe mucositis after acute substance ingestion. O'Connor JM; Nefcy A; Wilson SS Clin Toxicol (Phila); 2015 Jul; 53(6):578-9. PubMed ID: 25939901 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]